Vext Science, Inc. (“Vext” or the “Company”) (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that current Chief Financial Officer Daniel Engel, has decided to leave the Company to pursue an opportunity with a private equity backed company. Stephan Bankosz will take over as Vext’s interim CFO and Corporate Secretary while the Company considers internal and external candidates. Mr. Bankosz was appointed CFO of New Gen Holdings, Inc., (“New Gen”), Vext’s primary operating subsidiary, in January 2021. Additional finance resources will be recruited under Stephan to support Vext’s growth plans.
Eric Offenberger, CEO of Vext stated, “We wish Daniel well as he moves on and welcome Stephan as Vext’s interim CFO. Stephan has been a valuable addition to the team since joining as New Gen’s CFO in January last year. We expect a seamless transition, given Daniel’s very short tenure with Vext and Stephan’s deep knowledge of the Company’s current operations. We remain on track for an active and profitable 2022, as we continue to grow in Arizona, and initiate further expansion in Ohio, backed by a strong balance sheet, ongoing cash flow generation, and a team that has proven its ability to execute.”
Stephan Bankosz
Mr. Bankosz has over 25 years experience in financial management, operational control and risk management at leading manufacturing and distribution companies throughout the United States. His proven expertise in managing corporate profitability for growth companies has been valuable since his appointment as CFO of New Gen in January 2021, and will continue to be beneficial as Vext continues to execute its growth plans in Arizona and Ohio. Mr. Bankosz holds a Bachelor’s degree in accounting and management information systems and is a Microsoft Certified Systems Engineer, with specialized certification in over 20 accounting and distribution programs.
For more details, visit Vext’s investor website or contact the IR team at investors@vextscience.com.
